XML 68 R52.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share Based Compensation-Restricted and Performance Shares Rollforward (Details) - $ / shares
12 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Apr. 03, 2022
Performance-Based Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Beginning Balance, Shares 189,258 214,478 239,120
Granted, Shares 61,819 88,524 111,618
Vested, Shares (105,600) (102,860) (123,002)
Forfeited or expired, Shares   (10,884) (13,258)
Ending Balance, Shares 145,477 189,258 214,478
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Beginning Balance, Weighted average grant date fair value (usd per share) $ 34.64 $ 25.48 $ 17.94
Granted, Weighted average grant date fair value (usd per share) 43.06 38.31 31.74
Vested, Weighted average grant date fair value (usd per share) 31.74 18.69 17.25
Forfeited or expired, Weighted average grant date fair value (usd per share)   34.68 18.69
Ending Balance, Weighted average grant date fair value (usd per share) $ 40.33 $ 34.64 $ 25.48
Restricted Stock Awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Beginning Balance, Shares 12,565 10,287 11,228
Granted, Shares 10,647 12,565 10,287
Vested, Shares (12,565) (10,287) (11,228)
Ending Balance, Shares 10,647 12,565 10,287
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Beginning Balance, Weighted average grant date fair value (usd per share) $ 38.98 $ 32.80 $ 25.60
Granted, Weighted average grant date fair value (usd per share) 46.00 38.98 32.80
Vested, Weighted average grant date fair value (usd per share) 38.98 32.80 25.60
Ending Balance, Weighted average grant date fair value (usd per share) $ 46.00 $ 38.98 $ 32.80